Qu Biologics: Qu Biologics and TransBIOTech Awarded $450K Applied Research and Development Grant Funding
Qu Biologics Inc. is pleased to announce, in partnership with TransBIOTech (Quebec), being awarded an Applied Research and Development (ARD) grant via the College and Community Innovation (CCI) program administered through the Natural Sciences and Engineering.
Read full article »
Qu Biologics is a Canada-based biopharmaceutical company that researches and develops immunotherapies for the treatment of cancer and chronic inflammatory diseases.
Read more